Latest filing published 09 Jun 2025 for Oramed Pharmaceuticals INC..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 15 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +2.3%Entry US$3.00 · Close at T+365 US$3.07
- +4.4%Entry US$3.87 · Close at T+365 US$4.04
- +14.7%Entry US$3.54 · Close at T+365 US$4.06
- -20.5%Entry US$4.68 · Close at T+365 US$3.72
- +24.1%Entry US$3.48 · Close at T+365 US$4.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Leonard Sank: trading record in brief
Leonard Sank, listed as board member, appears in our data through filings on Oramed Pharmaceuticals Inc. shares, published by SEC (Form 4). Over a trading history stretching from 31 December 2007 to 5 June 2025, the count stands at 35 filings.
No open-market sale appears; the market trades are 15 purchases worth €527k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 14 share grants and 4 option exercises.
A typical purchase (the median) is worth €15k. No cluster: in 7 purchases, no other insider of the company bought within 30 days. Looking at 15 purchases old enough to measure, the stock rose over the following 90 days in 60% of cases; the median change was +72.7%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 9 June 2025, reports a share grant in Oramed Pharmaceuticals Inc. The latest purchase dates back some time: it was published 2,616 days ago, on 11 September 2019. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Leonard Sank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,510 sharesCommon StockSEC:0001213900-25-052620:1
- 30,000 sharesCommon StockSEC:0001213900-25-052620:0
- 9,325 sharesCommon StockSEC:0001209191-24-001143:1
- 30,000 sharesCommon StockSEC:0001209191-24-001143:0
- 30,000 sharesCommon StockSEC:0001209191-23-024942:0
- 9,304 shares@ US$8.774.2% of flowCommon StockSEC:0001209191-22-045207:1
- 20,000 shares@ US$4.08100.0% of flowCommon StockSEC:0001209191-22-045207:0
- 12,000 sharesCommon StockSEC:0001209191-22-043766:0
- 6,000 sharesCommon StockSEC:0001213900-22-000822:0
- 375,000 shares@ US$3.6861.8% of flowCommon StockSEC:0001213900-21-012894:0
- 78,125 shares@ US$3.6812.9% of flowCommon StockSEC:0001213900-21-012894:1
- 15,000 shares@ US$2.9012.1% of flowCommon StockSEC:0001213900-19-017770:0Canonical exit: 8 Dec 2019 (T+90)
- 10,000 shares@ US$2.958.2% of flowCommon StockSEC:0001213900-19-017770:1Canonical exit: 8 Dec 2019 (T+90)
- 20,000 shares@ US$3.4719.1% of flowCommon StockSEC:0001213900-19-013085:0Canonical exit: 14 Oct 2019 (T+90)
- 4,497 shares@ US$3.864.8% of flowCommon StockSEC:0001213900-19-013085:3Canonical exit: 16 Oct 2019 (T+90)
- 20,000 shares@ US$3.5819.7% of flowCommon StockSEC:0001213900-19-013085:1Canonical exit: 15 Oct 2019 (T+90)
- 10,020 shares@ US$3.7410.3% of flowCommon StockSEC:0001213900-19-013085:2Canonical exit: 15 Oct 2019 (T+90)
- 1,320 shares@ US$3.221.2% of flowCommon StockSEC:0001213900-19-012780:0Canonical exit: 9 Oct 2019 (T+90)
- 5,631 shares@ US$6.006.2% of flowCommon StockSEC:0001213900-17-010951:0
- 6,373 shares@ US$6.007.0% of flowCommon StockSEC:0001213900-17-010951:1
- 11,262 shares@ US$6.0012.3% of flowCommon StockSEC:0001213900-17-008889:0
- 3,000 shares@ US$8.574.9% of flowCommon StockSEC:0001213900-16-013724:0
- 22,178 shares0Common StockSEC:0001178913-15-000711:0
- 2,718 shares0Common StockSEC:0001178913-14-003601:0
- 12,745 sharesCommon StockSEC:0001178913-13-000312:0
25 of 35 declarations
